Anneke van der Walt

Summary

Affiliation: Royal Melbourne Hospital
Country: Australia

Publications

  1. doi request reprint The occurrence of dystonia in upper-limb multiple sclerosis tremor
    A van der Walt
    Department of Neurology, Royal Melbourne Hospital, Australia Melbourne Brain Centre, Department of Medicine at RMH, University of Melbourne, Australia Centre for Neuroscience, Department of Anatomy and Neuroscience, University of Melbourne, Australia
    Mult Scler 21:1847-55. 2015
  2. doi request reprint A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor
    Anneke van der Walt
    Royal Melbourne Hospital, Melbourne, Australia
    Neurology 79:92-9. 2012
  3. doi request reprint Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy
    A van der Walt
    Royal Melbourne Hospital, Department of Neurology, Parkville, Vic, Australia
    Neurology 73:1018-25. 2009
  4. doi request reprint Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade
    Anneke van der Walt
    The Royal Melbourne Hospital, Grattan St Parkville, Melbourne, Australia Centre for Neuroscience, University of Melbourne, Australia
    Pharmacol Ther 126:82-93. 2010
  5. doi request reprint Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition
    Anneke van der Walt
    Department of Neurology, The Royal Melbourne Hospital, Melbourne, Australia
    Mult Scler 17:344-52. 2011
  6. doi request reprint Parallel changes in structural and functional measures of optic nerve myelination after optic neuritis
    Anneke van der Walt
    Centre for Neuroscience, University of Melbourne, Melbourne, Australia Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia Department of Medicine, University of Melbourne, Melbourne, Australia
    PLoS ONE 10:e0121084. 2015
  7. pmc Optic nerve diffusion tensor imaging after acute optic neuritis predicts axonal and visual outcomes
    Anneke van der Walt
    Department of Anatomy and Neuroscience, University of Melbourne, Melbourne, Victoria, Australia Department of Neurology, Royal Melbourne Hospital, Melbourne, Victoria, Australia Department of Neuro ophthalmology, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia Melbourne Brain Centre at Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia
    PLoS ONE 8:e83825. 2013
  8. pmc Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients
    Cathy J Jensen
    Howard Florey Institute, Melbourne, Australia
    PLoS ONE 5:e10003. 2010
  9. pmc Optic nerve magnetisation transfer ratio after acute optic neuritis predicts axonal and visual outcomes
    Yejun Wang
    The Centre for Neuroscience Research, University of Melbourne, Parkville, Victoria, Australia
    PLoS ONE 7:e52291. 2012
  10. pmc Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis
    Tomas Kalincik
    Departments of Medicine and Neurology, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia
    PLoS ONE 8:e63480. 2013

Collaborators

  • Helmut Butzkueven
  • Scott Kolbe
  • J P Rubio
  • A Evans
  • Jim Stankovich
  • David R Booth
  • Steve Vucic
  • Alessandra Lugaresi
  • Gerardo Iuliano
  • Cavit Boz
  • Merrilee Needham
  • Liliana Patrucco
  • Lyn R Griffiths
  • Matthew A Brown
  • Melanie Bahlo
  • Simon J Foote
  • Sharon R Browning
  • David Williams
  • Tomas Kalincik
  • Mark Paine
  • Yejun Wang
  • Mark Slee
  • Trevor J Kilpatrick
  • Cathy J Jensen
  • Jodi Haartsen
  • Joab Chapman
  • Eugenio Pucci
  • Mark Marriott
  • Aldo Savino
  • Tatjana Petkovska-Boskova
  • Katherine Buzzard
  • Vahid Shaygannejad
  • Daniela Travaglini
  • Daniele La Spitaleri
  • Juan Ignacio Rojas
  • Maria Laura Saladino
  • Raymond Hupperts
  • Michael Barnett
  • Deborah Farina
  • Dieter Poehlau
  • Elaine Roger
  • Erik van Munster
  • Maria Edite Rio
  • Etienne Roullet
  • Jose Antonio Cabrera-Gomez
  • Carmen Adella Sîrbu
  • Orla Gray
  • Timothy Spelman
  • Luca Mancinelli
  • Eli Skromne
  • Edgardo Cristiano
  • Valeria Di Tommaso
  • Norma Deri
  • Roberto Bergamaschi
  • Guillermo Izquierdo
  • Joseph Herbert
  • Jorge Correale
  • Pietro Iaffaldano
  • Maria Trojano
  • Thor Petersen
  • Maria Di Ioia
  • Cees Zwanikken
  • Vetere Santiago
  • Leontien den Braber-Moerland
  • Freek Verheul
  • Giorgio Giuliani
  • François Grand'maison
  • Lisa Dark
  • Olga Skibina
  • Cartechini Elisabetta
  • Damiano Paolicelli
  • Pierre Despault
  • Jeannette Lechner-Scott
  • Pierre Grammond
  • Sholmo Flechter
  • Erika Pietrolongo
  • Trevor Kilpatrick
  • Walter Oleschko Arruda
  • Krisztian Kasa
  • Vilija Jokubaitis
  • Cameron Shaw
  • Fraser Moore
  • Bhim Singhal
  • Norbert Vella
  • Vincent van Pesch
  • Pierre Duquette
  • Celia Oreja-Guevara
  • Jill Byron
  • Marcela Fiol
  • Ricardo Fernández-Bolaños

Detail Information

Publications10

  1. doi request reprint The occurrence of dystonia in upper-limb multiple sclerosis tremor
    A van der Walt
    Department of Neurology, Royal Melbourne Hospital, Australia Melbourne Brain Centre, Department of Medicine at RMH, University of Melbourne, Australia Centre for Neuroscience, Department of Anatomy and Neuroscience, University of Melbourne, Australia
    Mult Scler 21:1847-55. 2015
    ..The pathophysiology of multiple sclerosis (MS) tremor is uncertain with limited phenotypical studies available...
  2. doi request reprint A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor
    Anneke van der Walt
    Royal Melbourne Hospital, Melbourne, Australia
    Neurology 79:92-9. 2012
    ..To evaluate the safety and efficacy of botulinum toxin type A in disabling multiple sclerosis (MS)-related upper limb tremor...
  3. doi request reprint Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy
    A van der Walt
    Royal Melbourne Hospital, Department of Neurology, Parkville, Vic, Australia
    Neurology 73:1018-25. 2009
    ..In this study, we examine the influence of heterogeneity of the APOE gene on disease severity in a large, Australian, population-based MS cohort...
  4. doi request reprint Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade
    Anneke van der Walt
    The Royal Melbourne Hospital, Grattan St Parkville, Melbourne, Australia Centre for Neuroscience, University of Melbourne, Australia
    Pharmacol Ther 126:82-93. 2010
    ..In this article, we will discuss some of the principal therapeutic candidates that could provide neuroprotection in MS and emerging methodologies by which to test them...
  5. doi request reprint Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition
    Anneke van der Walt
    Department of Neurology, The Royal Melbourne Hospital, Melbourne, Australia
    Mult Scler 17:344-52. 2011
    ..We examined the influence of DR15 and other common DRB1 alleles (DRB1*01 (DR1), DRB1*03 (DR3) and DRB1*04 (DR4) on MS severity in a large, Australian, population-based cohort...
  6. doi request reprint Parallel changes in structural and functional measures of optic nerve myelination after optic neuritis
    Anneke van der Walt
    Centre for Neuroscience, University of Melbourne, Melbourne, Australia Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia Department of Medicine, University of Melbourne, Melbourne, Australia
    PLoS ONE 10:e0121084. 2015
    ..We aimed to investigate the relationship between multifocal VEP (mfVEP) latency and optic nerve lesion length after acute ON...
  7. pmc Optic nerve diffusion tensor imaging after acute optic neuritis predicts axonal and visual outcomes
    Anneke van der Walt
    Department of Anatomy and Neuroscience, University of Melbourne, Melbourne, Victoria, Australia Department of Neurology, Royal Melbourne Hospital, Melbourne, Victoria, Australia Department of Neuro ophthalmology, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia Melbourne Brain Centre at Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia
    PLoS ONE 8:e83825. 2013
    ..Early markers of axonal and clinical outcomes are required for early phase testing of putative neuroprotective therapies for multiple sclerosis (MS)...
  8. pmc Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients
    Cathy J Jensen
    Howard Florey Institute, Melbourne, Australia
    PLoS ONE 5:e10003. 2010
    ..No associations were significant after correction for multiple testing. We found no evidence for the hypothesis that these new MS disease risk-associated SNPs influence disease severity...
  9. pmc Optic nerve magnetisation transfer ratio after acute optic neuritis predicts axonal and visual outcomes
    Yejun Wang
    The Centre for Neuroscience Research, University of Melbourne, Parkville, Victoria, Australia
    PLoS ONE 7:e52291. 2012
    ..59, p = 0.02). In conclusion, these findings indicate that MTR flux after acute ON is predictive of axonal degeneration and visual disability outcomes...
  10. pmc Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis
    Tomas Kalincik
    Departments of Medicine and Neurology, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia
    PLoS ONE 8:e63480. 2013
    ....